Why is Panacea Biotec falling/rising?

As of 06-Nov, Panacea Biotec Ltd is experiencing a decline in its stock price, currently at Rs 407.00, reflecting a decrease of Rs 25.3 or 5.85%. The stock has underperformed its sector by 5.08% today, touching an intraday low of Rs 407. It is trading below all key moving averages, indicating a bearish trend. Over the past week, the stock has dropped by 7.90%, while it has shown a modest gain of 5.14% over the past year. Despite some positive factors, such as increased institutional investor participation and consistent returns over the last three years, the company faces significant challenges, including operating losses and a weak ability to service its debt, which contribute to its negative sentiment in the market.
In the broader market context, the Sensex has only declined by 1.30% over the past week, highlighting that Panacea Biotec's performance is significantly worse than the overall market. While the stock has generated a return of 5.14% over the past year, this is overshadowed by the company's poor long-term growth prospects, as indicated by a negative EBIT to interest ratio and declining operating profits. The liquidity of the stock remains adequate for trading, but the overall negative sentiment surrounding its financial health and performance compared to the benchmark suggests that investors are cautious, leading to the current downward trend in its stock price.